IRLAB publishes the Annual Report for 2022

GOTHENBURG, SE / ACCESSWIRE / April 28, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company that discovers and develops new treatments for Parkinson's disease, announced today that the Annual Report for 2022 is published on the company's …